MATENOL MR is indicated in adults as add-on therapy for the symptomatic treatment of patients with stable angina pectoris who are inadequately controlled by or intolerant to first-line antianginal therapies.
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.